GlassScriptPhysician profile
Veronica Lopez
NPI 1841671278
$2,103.38
in general payments reported to CMS, 2019-2025
10 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $168 · 2024: $326 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106 · Travel and Lodging: $910 · Education: $87.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.63 |
| Travel and Lodging | $909.76 |
| Education | $87.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,417.92 | 2023-2025 | Inspire |
| Harmony Biosciences LLC | $156.67 | 2024-2025 | |
| Lilly USA, LLC | $118.43 | 2024-2025 | Mounjaro, Zepbound |
| Abiomed | $114.93 | 2024 | Impella |
| Glaxosmithkline, LLC. | $103.93 | 2025 | Arexvy |
| Abbvie INC. | $99.56 | 2023 | |
| Jazz Pharmaceuticals INC. | $33.08 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $20.58 | 2025 | Lumryz |
| Viiv Healthcare Company | $19.77 | 2024 | Apretude |
| Philips North America LLC | $18.51 | 2024 | (6299) Dreamwear |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.